×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Spinal needles Market Share

    ID: MRFR/MED/0709-HCR
    80 Pages
    Kinjoll Dey
    October 2025

    Spinal Needles Market Research Report Information By Type (Atraumatic Needles, Directional Spinal Needles, and Pencil-Point Needles), Application (Therapeutic and Diagnostic), End-User (Hospitals & Clinics, Diagnostic Centers, Research Laboratories, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East and Africa)—Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Spinal needles Market Infographic
    Purchase Options

    Market Share

    Spinal needles Market Share Analysis

    One key methodology includes item separation. Organizations endeavor to offer creative elements in their spinal needles, like ergonomic plans or high-level materials, to stand out from contenders. This draws in medical services experts as well as upgrades the general offer for end-clients. Another critical methodology is cost administration. A few organizations center around economies of scale, utilizing their creation capacities to lessen expenses and deal more reasonable spinal needles without compromising quality. This methodology targets cost sensitive sections of the market and encourages more extensive market entry. A few organizations decide to practice and target specialty markets inside the bigger spinal needles market. This includes creating items custom fitted to specific operations or patient socioeconomics. By becoming specialists in a specific specialty, organizations can set up a good foundation for themselves as pioneers in that section. Remaining ahead in the market frequently requires constant advancement. Organizations put fundamentally in innovative work to present new advancements and enhancements in spinal needle plan. This system not just draws in medical services experts looking for cutting edge hardware yet additionally guarantees long haul manageability. Building major areas of strength for an and successful marketing are essential parts of market share situating. Organizations put resources into making brand awareness, stressing the quality and dependability of their spinal needles. Taking part in designated marketing efforts helps impact medical care experts' inclinations and cultivates brand dependability. The market is dynamic, with innovative headways and changing medical care landscapes. Consistent observing of market patterns, contender exercises, and client criticism is fundamental. Organizations that can rapidly adjust their methodologies considering these pieces of knowledge are better situated to keep up with and improve their market share.

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    What is the projected growth of the Spinal Needles market?

    The Spinal Needles market is the expected increase in total market value of 0.69 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Spinal Needles market?

    Spinal Needles market size was valued at approximately 0.33 billion USD in 2024. This figure will reach 0.69 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Spinal Needles market?

    Spinal Needles market is expected to grow at a CAGR of 6.91% between 2025 and 2035.

    How much will the Spinal Needles market be worth by 2035?

    Spinal Needles market is expected to be worth of 0.69 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Spinal Needles market perform over the next 10 years?

    Over the next 10 years the Spinal Needles market is expected to shift from usd billion 0.33 to 0.69 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the spinal needles market?

    The Americas spinal needles market held the largest market share during the study period.

    Who are the key players in the spinal needles market?

    Braun Melsungen AG (US), Stryker Corporation (US), Boston Scientific Corporation (US), Becton, Dickinson, and Company (US), Smith’s Medical (US),Myco Medical (US),Argon Medical (US),Exelint International, Co. (US).

    Which type had the largest market share in the spinal needles market?

    The pencil-point needles segment held the majority share in 2024 contributing to around 40% with respect to the Spinal Needles Market.

    Market Summary

    As per MRFR analysis, the Spinal Needles Market Size was estimated at 0.33 USD Billion in 2024. The Spinal Needles industry is projected to grow from 0.3528 in 2025 to 0.6883 by 2035, exhibiting a compound annual growth rate (CAGR) of 6.91 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Spinal Needles Market is experiencing robust growth driven by technological advancements and increasing demand for minimally invasive procedures.

    • Technological advancements are enhancing the efficacy and safety of spinal needle procedures.
    • North America remains the largest market, while Asia-Pacific is recognized as the fastest-growing region.
    • Pencil-point needles dominate the market, whereas directional spinal needles are emerging as the fastest-growing segment.
    • The rising prevalence of chronic pain and advancements in medical technology are key drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 0.33 (USD Billion)
    2035 Market Size 0.6883 (USD Billion)
    CAGR (2025 - 2035) 6.91%
    Largest Regional Market Share in 2024 Europe

    Major Players

    <p>B. Braun Melsungen AG (DE), Medtronic plc (IE), Teleflex Incorporated (US), Smiths Medical (US), Halyard Health, Inc. (US), Stryker Corporation (US), Boston Scientific Corporation (US), Nipro Corporation (JP)</p>

    Market Trends

    The Spinal Needles Market is currently experiencing a notable evolution, driven by advancements in medical technology and an increasing demand for minimally invasive procedures. Healthcare professionals are increasingly adopting spinal needles that offer enhanced precision and reduced patient discomfort. This shift is likely influenced by a growing awareness of the benefits associated with these devices, including improved patient outcomes and shorter recovery times. Furthermore, the rising prevalence of chronic pain conditions and the aging population are contributing to the heightened need for effective spinal interventions. As a result, manufacturers are focusing on innovation and product development to meet the changing needs of healthcare providers and patients alike. In addition, regulatory bodies are playing a crucial role in shaping the Spinal Needles Market landscape. Stringent regulations regarding product safety and efficacy are prompting companies to invest in research and development. This regulatory environment may foster a competitive atmosphere, encouraging firms to enhance their offerings. Moreover, the integration of digital technologies in healthcare is likely to influence the market dynamics, as telemedicine and remote monitoring become more prevalent. Overall, the Spinal Needles Market appears poised for growth, with various factors indicating a promising future for both manufacturers and healthcare providers.

    Technological Advancements

    The Spinal Needles Market is witnessing a surge in technological innovations, particularly in needle design and materials. Enhanced imaging techniques and smart needles are emerging, which may improve accuracy during procedures. These advancements could lead to better patient outcomes and increased adoption rates among healthcare professionals.

    Rising Demand for Minimally Invasive Procedures

    There is a growing trend towards minimally invasive surgical techniques within the Spinal Needles Market. Patients and healthcare providers alike are favoring procedures that reduce recovery time and minimize discomfort. This shift is likely to drive the demand for spinal needles that facilitate such interventions.

    Regulatory Influence on Product Development

    Regulatory bodies are increasingly impacting the Spinal Needles Market by enforcing stringent safety and efficacy standards. This regulatory landscape may compel manufacturers to prioritize quality and innovation in their product offerings, potentially leading to enhanced safety profiles and improved market competitiveness.

    Spinal needles Market Market Drivers

    Advancements in Medical Technology

    Technological innovations in the medical field are significantly influencing the Spinal Needles Market. The introduction of advanced materials and designs, such as ultra-thin needles and safety-engineered devices, enhances the precision and safety of spinal procedures. These advancements not only improve patient outcomes but also reduce the risk of complications associated with spinal interventions. The market is witnessing a shift towards the adoption of smart spinal needles equipped with sensors that provide real-time feedback during procedures. This trend is expected to drive the growth of the Spinal Needles Market as healthcare providers increasingly prioritize patient safety and procedural accuracy. Moreover, the integration of imaging technologies with spinal needle procedures is likely to further enhance the effectiveness of these interventions.

    Increasing Prevalence of Chronic Pain

    The rising incidence of chronic pain conditions, such as lower back pain and neuropathic pain, is a primary driver for the Spinal Needles Market. According to recent estimates, chronic pain affects a significant portion of the population, leading to an increased demand for effective pain management solutions. Spinal needles are essential for procedures like epidurals and spinal anesthesia, which are commonly employed to alleviate pain. As healthcare providers seek to address this growing issue, the Spinal Needles Market is likely to experience substantial growth. Furthermore, the aging population, which is more susceptible to chronic pain, further amplifies this demand. The need for innovative and efficient spinal needle designs that enhance patient comfort and procedural efficacy is becoming increasingly apparent.

    Regulatory Support for Innovative Products

    Regulatory bodies are increasingly supporting the development of innovative products within the Spinal Needles Market. Streamlined approval processes for new spinal needle designs and technologies are encouraging manufacturers to invest in research and development. This regulatory environment fosters innovation, allowing for the introduction of safer and more effective spinal needles. Additionally, the emphasis on patient safety and quality assurance in regulatory frameworks is likely to enhance the credibility of products in the market. As a result, healthcare providers may be more inclined to adopt new spinal needle technologies that align with regulatory standards. This trend is expected to contribute positively to the growth trajectory of the Spinal Needles Market, as manufacturers respond to regulatory incentives by developing cutting-edge solutions.

    Rising Demand for Pain Management Solutions

    The increasing focus on effective pain management strategies is propelling the Spinal Needles Market forward. As healthcare systems worldwide prioritize patient-centered care, the demand for spinal interventions, including epidural injections and spinal anesthesia, is on the rise. The World Health Organization has highlighted the importance of addressing pain as a critical component of healthcare, which has led to a surge in the utilization of spinal needles for various therapeutic applications. This trend is further supported by the growing awareness among patients regarding available pain management options. Consequently, the Spinal Needles Market is likely to expand as healthcare providers seek to meet the rising expectations of patients for effective and minimally invasive pain relief solutions.

    Growing Awareness of Minimally Invasive Techniques

    The increasing awareness and acceptance of minimally invasive techniques among healthcare professionals and patients are driving the Spinal Needles Market. Minimally invasive procedures are associated with reduced recovery times, lower complication rates, and improved patient satisfaction. As a result, there is a growing preference for spinal interventions that utilize spinal needles, such as epidural injections and spinal anesthesia. This shift in preference is supported by educational initiatives and training programs aimed at enhancing the skills of healthcare providers in performing these procedures. The Spinal Needles Market is likely to benefit from this trend, as more practitioners adopt minimally invasive techniques to meet the evolving needs of patients seeking effective and less invasive treatment options.

    Market Segment Insights

    Spinal Needles Type Insights

    The Spinal Needles Market segmentation, based on type, includes pencil-point needles, directional spinal needles, and pencil-point needles. The pencil-point needles segment is to hold the majority share in 2021 in the Spinal Needles Market revenue. This is due to the collective efforts of the organization/ universities to effectively deploy it.

    In addition, the role of CTMS in the campus-wide adoption was to support multi-dimensional investigations, cancer trials, and pharmaceutical research. Leading companies in the pharmaceutical industry use enterprise-wide types like impact CTMS.

    January 2021 Stryker Corporation (US) acquired OrthoSensor, Inc. (US), a market leader in providing digital care in musculoskeletal care and total joint replacement sensor technology. The move will help the company innovate novel treatments, in the spinal segment as well.

    Spinal Needles Application Insights

    The Spinal Needles Market segmentation is based on an application that includes, therapeutic, diagnostic. The therapeutic segment has dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032.

    This is because the spinal needles are used to inject analgesia and/or anesthetic directly into the cerebrospinal fluid. Spinal needles enter the cerebral spinal fluid (CSF) through the membranes surrounding the spinal cord. Some of the notable products in the spinal needle market include Sprotte spinal needle by Pajunk (Germany), Whitacre-Pencil point spinal anesthesia needle by Becton, Dickinson and Company (US), and Quincke spinal needle by Vygon SA (France). The utility of spinal needles is increasing with the recently increasing number of clinical investigations.

    Figure 2 SPINAL NEEDLES MARKET, BY TYPE, 2021 & 2032 (USD BILLION)

    Source Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Spinal Needles End User Insights

    The Spinal Needles Market segmentation is based on end-user that includes hospitals & clinics, diagnostic centers, research laboratories, and others. The hospitals & clinics segment has dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032.

    This is due to the increasing number of patients getting monitored with spinal disorders. Since advanced and complete treatments are available in the hospital, patients normally prefer to get treated at the hospital. A spinal anesthetic is used for lower abdominal, pelvic, rectal, or lower extremity surgery. Clinics are also medical care centers that provide care for patients suffering from various neurodegenerative diseases.

    December 2020 Smiths Medical (US) launched its Portex EchoGlo needle portfolio which work for echogenic brightness under ultrasound and are designed to make medication delivery more efficient and accurate. This further improves the companies pain management product portfolio.

    Get more detailed insights about Spinal Needles Market Research Report-Forecast till 2035

    Regional Insights

    North America : Market Leader in Innovation

    North America is the largest market for spinal needles, accounting for approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of spinal disorders, and a strong emphasis on research and development. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical devices. The United States leads the North American market, with significant contributions from Canada. Key players such as Medtronic, Teleflex, and Smiths Medical dominate the landscape, focusing on innovative product development and strategic partnerships. The competitive environment is characterized by continuous advancements in technology and a growing demand for minimally invasive procedures, enhancing patient outcomes.

    Europe : Emerging Regulatory Frameworks

    Europe is the second-largest market for spinal needles, holding around 30% of the global share. The region's growth is propelled by increasing surgical procedures, a rising geriatric population, and stringent regulatory frameworks that ensure product safety. The European Medicines Agency (EMA) plays a crucial role in overseeing medical device regulations, fostering innovation while maintaining high safety standards. Leading countries in Europe include Germany, France, and the UK, where key players like B. Braun Melsungen AG and Stryker Corporation are prominent. The competitive landscape is marked by a focus on technological advancements and collaborations among manufacturers to enhance product offerings. The presence of well-established healthcare systems further supports market growth, driving demand for advanced spinal needle solutions.

    Asia-Pacific : Rapidly Growing Market Potential

    Asia-Pacific is witnessing rapid growth in the spinal needles market, accounting for approximately 20% of the global share. The region's expansion is driven by increasing healthcare expenditure, a growing population, and rising awareness of spinal health. Countries like China and India are at the forefront, supported by government initiatives aimed at improving healthcare access and quality. China is the largest market in the region, followed by India and Japan. The competitive landscape features both local and international players, including Nipro Corporation and Medtronic. The market is characterized by a surge in demand for advanced medical technologies and a shift towards minimally invasive surgical techniques, which are expected to drive further growth in the coming years.

    Middle East and Africa : Untapped Market Opportunities

    The Middle East and Africa represent an emerging market for spinal needles, holding about 5% of the global share. The growth in this region is driven by increasing healthcare investments, a rising prevalence of spinal disorders, and a growing awareness of advanced medical technologies. Governments are focusing on improving healthcare infrastructure, which is expected to enhance market dynamics significantly. Leading countries in this region include South Africa and the UAE, where there is a growing presence of international players. The competitive landscape is evolving, with local manufacturers beginning to emerge alongside established companies. The market is characterized by a demand for innovative solutions and a gradual shift towards advanced healthcare practices, indicating significant growth potential in the coming years.

    Key Players and Competitive Insights

    The Spinal Needles Market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid technological advances, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.

    The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs. In August 2020, B. Braun (Germany) received the US FDA approval for its Onvision ultrasound guidance needle tip tracking solution, aiming to drastically improve success rates in regional anesthesia procedures. In September 2019, B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution, which works in real-time for regional anesthesia processes.

    The Spinal Needles Market is extremely competitive, with players investing heavily in R&D to create product differentiation and gain a significant market share.

    Key Companies in the Spinal needles Market market include

    Industry Developments

    December 2020 Smiths Medical (US) launched its Portex EchoGlo needle portfolio which work for echogenic brightness under ultrasound and are designed to make medication delivery more efficient and accurate. This further improves the companies pain management product portfolio.

    September 2019 B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution which works in real-time for regional anaesthesia processes. This works in line with Philip’s ultrasound system, making anaesthesia processes safer and more accurate.

    January 2021 Stryker Corporation (US) acquired OrthoSensor, Inc. (US), a market leader in providing digital care in musculoskeletal care and total joint replacement sensor technology. The move will help the company innovate novel treatments, in the spinal segment as well.

    December 2020 Argon Medical (US) acquired Mana-Tech, Ltd. (UK) which was its exclusive product distributor in the UK and Ireland. This move helped the company to expand its reach throughout Europe.

    November 2020 Medtronic plc (Ireland) acquired Medicrea (France) to become the first company to provide Artificial Intelligence (AI) driven spinal surgery planning, implant, and robotic surgery with the help of Medicrea Ai capabilities.

    Future Outlook

    Spinal needles Market Future Outlook

    <p>The Spinal Needles Market is projected to grow at a 6.91% CAGR from 2024 to 2035, driven by technological advancements, increasing surgical procedures, and rising demand for minimally invasive techniques.</p>

    New opportunities lie in:

    • <p>Development of smart spinal needles with integrated sensors for real-time feedback.</p>
    • <p>Expansion into emerging markets with tailored product offerings.</p>
    • <p>Partnerships with hospitals for exclusive supply agreements and training programs.</p>

    <p>By 2035, the Spinal Needles Market is expected to achieve substantial growth and innovation.</p>

    Market Segmentation

    Spinal Needles Type Outlook

    • Pencil-Point Needles
    • Directional Spinal Needles
    • Atraumatic Needles

    Spinal Needles End User Outlook

    • Hospitals & Clinics
    • Diagnostic Centers
    • Research Laboratories
    • Speciality Centres

    Spinal Needles Regional Outlook

    North America
    • Braun Melsungen AG (US)
    • Stryker Corporation (US)
    • Boston Scientific Corporation (US)
    • Becton, Dickinson, and Company (US)
    • Smith’s Medical (US)
    • Myco Medical (US)
    • Argon Medical (US)
    • Exelint International, Co. (US)
    • Pencil-Point Needles
    • Directional Spinal Needles
    • Atraumatic Needles
    • Therapeutic
    • Diagnostic
    • Hospitals & Clinics
    • Diagnostic Centers
    • Research Laboratories
    • Speciality Centres
    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa

    Spinal Needles Application Outlook

    • Therapeutic
    • Diagnostic

    Report Scope

    MARKET SIZE 20240.33(USD Billion)
    MARKET SIZE 20250.3528(USD Billion)
    MARKET SIZE 20350.6883(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)6.91% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in minimally invasive techniques enhance growth potential in the Spinal Needles Market.
    Key Market DynamicsTechnological advancements and regulatory changes are reshaping competitive dynamics in the spinal needles market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    FAQs

    What is the projected growth of the Spinal Needles market?

    The Spinal Needles market is the expected increase in total market value of 0.69 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Spinal Needles market?

    Spinal Needles market size was valued at approximately 0.33 billion USD in 2024. This figure will reach 0.69 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Spinal Needles market?

    Spinal Needles market is expected to grow at a CAGR of 6.91% between 2025 and 2035.

    How much will the Spinal Needles market be worth by 2035?

    Spinal Needles market is expected to be worth of 0.69 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Spinal Needles market perform over the next 10 years?

    Over the next 10 years the Spinal Needles market is expected to shift from usd billion 0.33 to 0.69 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the spinal needles market?

    The Americas spinal needles market held the largest market share during the study period.

    Who are the key players in the spinal needles market?

    Braun Melsungen AG (US), Stryker Corporation (US), Boston Scientific Corporation (US), Becton, Dickinson, and Company (US), Smith’s Medical (US),Myco Medical (US),Argon Medical (US),Exelint International, Co. (US).

    Which type had the largest market share in the spinal needles market?

    The pencil-point needles segment held the majority share in 2024 contributing to around 40% with respect to the Spinal Needles Market.

    1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
      1. | 1.1 EXECUTIVE SUMMARY
      2. | | 1.1.1 Market Overview
      3. | | 1.1.2 Key Findings
      4. | | 1.1.3 Market Segmentation
      5. | | 1.1.4 Competitive Landscape
      6. | | 1.1.5 Challenges and Opportunities
      7. | | 1.1.6 Future Outlook
    2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
      1. | 2.1 MARKET INTRODUCTION
      2. | | 2.1.1 Definition
      3. | | 2.1.2 Scope of the study
      4. | | | 2.1.2.1 Research Objective
      5. | | | 2.1.2.2 Assumption
      6. | | | 2.1.2.3 Limitations
      7. | 2.2 RESEARCH METHODOLOGY
      8. | | 2.2.1 Overview
      9. | | 2.2.2 Data Mining
      10. | | 2.2.3 Secondary Research
      11. | | 2.2.4 Primary Research
      12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
      13. | | | 2.2.4.2 Breakdown of Primary Respondents
      14. | | 2.2.5 Forecasting Model
      15. | | 2.2.6 Market Size Estimation
      16. | | | 2.2.6.1 Bottom-Up Approach
      17. | | | 2.2.6.2 Top-Down Approach
      18. | | 2.2.7 Data Triangulation
      19. | | 2.2.8 Validation
    3. SECTION III: QUALITATIVE ANALYSIS
      1. | 3.1 MARKET DYNAMICS
      2. | | 3.1.1 Overview
      3. | | 3.1.2 Drivers
      4. | | 3.1.3 Restraints
      5. | | 3.1.4 Opportunities
      6. | 3.2 MARKET FACTOR ANALYSIS
      7. | | 3.2.1 Value chain Analysis
      8. | | 3.2.2 Porter's Five Forces Analysis
      9. | | | 3.2.2.1 Bargaining Power of Suppliers
      10. | | | 3.2.2.2 Bargaining Power of Buyers
      11. | | | 3.2.2.3 Threat of New Entrants
      12. | | | 3.2.2.4 Threat of Substitutes
      13. | | | 3.2.2.5 Intensity of Rivalry
      14. | | 3.2.3 COVID-19 Impact Analysis
      15. | | | 3.2.3.1 Market Impact Analysis
      16. | | | 3.2.3.2 Regional Impact
      17. | | | 3.2.3.3 Opportunity and Threat Analysis
    4. SECTION IV: QUANTITATIVE ANALYSIS
      1. | 4.1 Healthcare, BY Type (USD Billion)
      2. | | 4.1.1 Pencil-Point Needles
      3. | | 4.1.2 Directional Spinal Needles
      4. | | 4.1.3 Atraumatic Needles
      5. | 4.2 Healthcare, BY Application (USD Billion)
      6. | | 4.2.1 Therapeutic
      7. | | 4.2.2 Diagnostic
      8. | 4.3 Healthcare, BY End User (USD Billion)
      9. | | 4.3.1 Hospitals & Clinics
      10. | | 4.3.2 Diagnostic Centers
      11. | | 4.3.3 Research Laboratories
      12. | | 4.3.4 Speciality Centres
      13. | 4.4 Healthcare, BY Region (USD Billion)
      14. | | 4.4.1 North America
      15. | | | 4.4.1.1 US
      16. | | | 4.4.1.2 Canada
      17. | | 4.4.2 Europe
      18. | | | 4.4.2.1 Germany
      19. | | | 4.4.2.2 UK
      20. | | | 4.4.2.3 France
      21. | | | 4.4.2.4 Russia
      22. | | | 4.4.2.5 Italy
      23. | | | 4.4.2.6 Spain
      24. | | | 4.4.2.7 Rest of Europe
      25. | | 4.4.3 APAC
      26. | | | 4.4.3.1 China
      27. | | | 4.4.3.2 India
      28. | | | 4.4.3.3 Japan
      29. | | | 4.4.3.4 South Korea
      30. | | | 4.4.3.5 Malaysia
      31. | | | 4.4.3.6 Thailand
      32. | | | 4.4.3.7 Indonesia
      33. | | | 4.4.3.8 Rest of APAC
      34. | | 4.4.4 South America
      35. | | | 4.4.4.1 Brazil
      36. | | | 4.4.4.2 Mexico
      37. | | | 4.4.4.3 Argentina
      38. | | | 4.4.4.4 Rest of South America
      39. | | 4.4.5 MEA
      40. | | | 4.4.5.1 GCC Countries
      41. | | | 4.4.5.2 South Africa
      42. | | | 4.4.5.3 Rest of MEA
    5. SECTION V: COMPETITIVE ANALYSIS
      1. | 5.1 Competitive Landscape
      2. | | 5.1.1 Overview
      3. | | 5.1.2 Competitive Analysis
      4. | | 5.1.3 Market share Analysis
      5. | | 5.1.4 Major Growth Strategy in the Healthcare
      6. | | 5.1.5 Competitive Benchmarking
      7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      8. | | 5.1.7 Key developments and growth strategies
      9. | | | 5.1.7.1 New Product Launch/Service Deployment
      10. | | | 5.1.7.2 Merger & Acquisitions
      11. | | | 5.1.7.3 Joint Ventures
      12. | | 5.1.8 Major Players Financial Matrix
      13. | | | 5.1.8.1 Sales and Operating Income
      14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
      15. | 5.2 Company Profiles
      16. | | 5.2.1 B. Braun Melsungen AG (DE)
      17. | | | 5.2.1.1 Financial Overview
      18. | | | 5.2.1.2 Products Offered
      19. | | | 5.2.1.3 Key Developments
      20. | | | 5.2.1.4 SWOT Analysis
      21. | | | 5.2.1.5 Key Strategies
      22. | | 5.2.2 Medtronic plc (IE)
      23. | | | 5.2.2.1 Financial Overview
      24. | | | 5.2.2.2 Products Offered
      25. | | | 5.2.2.3 Key Developments
      26. | | | 5.2.2.4 SWOT Analysis
      27. | | | 5.2.2.5 Key Strategies
      28. | | 5.2.3 Teleflex Incorporated (US)
      29. | | | 5.2.3.1 Financial Overview
      30. | | | 5.2.3.2 Products Offered
      31. | | | 5.2.3.3 Key Developments
      32. | | | 5.2.3.4 SWOT Analysis
      33. | | | 5.2.3.5 Key Strategies
      34. | | 5.2.4 Smiths Medical (US)
      35. | | | 5.2.4.1 Financial Overview
      36. | | | 5.2.4.2 Products Offered
      37. | | | 5.2.4.3 Key Developments
      38. | | | 5.2.4.4 SWOT Analysis
      39. | | | 5.2.4.5 Key Strategies
      40. | | 5.2.5 Halyard Health, Inc. (US)
      41. | | | 5.2.5.1 Financial Overview
      42. | | | 5.2.5.2 Products Offered
      43. | | | 5.2.5.3 Key Developments
      44. | | | 5.2.5.4 SWOT Analysis
      45. | | | 5.2.5.5 Key Strategies
      46. | | 5.2.6 Stryker Corporation (US)
      47. | | | 5.2.6.1 Financial Overview
      48. | | | 5.2.6.2 Products Offered
      49. | | | 5.2.6.3 Key Developments
      50. | | | 5.2.6.4 SWOT Analysis
      51. | | | 5.2.6.5 Key Strategies
      52. | | 5.2.7 Boston Scientific Corporation (US)
      53. | | | 5.2.7.1 Financial Overview
      54. | | | 5.2.7.2 Products Offered
      55. | | | 5.2.7.3 Key Developments
      56. | | | 5.2.7.4 SWOT Analysis
      57. | | | 5.2.7.5 Key Strategies
      58. | | 5.2.8 Nipro Corporation (JP)
      59. | | | 5.2.8.1 Financial Overview
      60. | | | 5.2.8.2 Products Offered
      61. | | | 5.2.8.3 Key Developments
      62. | | | 5.2.8.4 SWOT Analysis
      63. | | | 5.2.8.5 Key Strategies
      64. | 5.3 Appendix
      65. | | 5.3.1 References
      66. | | 5.3.2 Related Reports
    6. LIST OF FIGURES
      1. | 6.1 MARKET SYNOPSIS
      2. | 6.2 NORTH AMERICA MARKET ANALYSIS
      3. | 6.3 US MARKET ANALYSIS BY TYPE
      4. | 6.4 US MARKET ANALYSIS BY APPLICATION
      5. | 6.5 US MARKET ANALYSIS BY END USER
      6. | 6.6 CANADA MARKET ANALYSIS BY TYPE
      7. | 6.7 CANADA MARKET ANALYSIS BY APPLICATION
      8. | 6.8 CANADA MARKET ANALYSIS BY END USER
      9. | 6.9 EUROPE MARKET ANALYSIS
      10. | 6.10 GERMANY MARKET ANALYSIS BY TYPE
      11. | 6.11 GERMANY MARKET ANALYSIS BY APPLICATION
      12. | 6.12 GERMANY MARKET ANALYSIS BY END USER
      13. | 6.13 UK MARKET ANALYSIS BY TYPE
      14. | 6.14 UK MARKET ANALYSIS BY APPLICATION
      15. | 6.15 UK MARKET ANALYSIS BY END USER
      16. | 6.16 FRANCE MARKET ANALYSIS BY TYPE
      17. | 6.17 FRANCE MARKET ANALYSIS BY APPLICATION
      18. | 6.18 FRANCE MARKET ANALYSIS BY END USER
      19. | 6.19 RUSSIA MARKET ANALYSIS BY TYPE
      20. | 6.20 RUSSIA MARKET ANALYSIS BY APPLICATION
      21. | 6.21 RUSSIA MARKET ANALYSIS BY END USER
      22. | 6.22 ITALY MARKET ANALYSIS BY TYPE
      23. | 6.23 ITALY MARKET ANALYSIS BY APPLICATION
      24. | 6.24 ITALY MARKET ANALYSIS BY END USER
      25. | 6.25 SPAIN MARKET ANALYSIS BY TYPE
      26. | 6.26 SPAIN MARKET ANALYSIS BY APPLICATION
      27. | 6.27 SPAIN MARKET ANALYSIS BY END USER
      28. | 6.28 REST OF EUROPE MARKET ANALYSIS BY TYPE
      29. | 6.29 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
      30. | 6.30 REST OF EUROPE MARKET ANALYSIS BY END USER
      31. | 6.31 APAC MARKET ANALYSIS
      32. | 6.32 CHINA MARKET ANALYSIS BY TYPE
      33. | 6.33 CHINA MARKET ANALYSIS BY APPLICATION
      34. | 6.34 CHINA MARKET ANALYSIS BY END USER
      35. | 6.35 INDIA MARKET ANALYSIS BY TYPE
      36. | 6.36 INDIA MARKET ANALYSIS BY APPLICATION
      37. | 6.37 INDIA MARKET ANALYSIS BY END USER
      38. | 6.38 JAPAN MARKET ANALYSIS BY TYPE
      39. | 6.39 JAPAN MARKET ANALYSIS BY APPLICATION
      40. | 6.40 JAPAN MARKET ANALYSIS BY END USER
      41. | 6.41 SOUTH KOREA MARKET ANALYSIS BY TYPE
      42. | 6.42 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
      43. | 6.43 SOUTH KOREA MARKET ANALYSIS BY END USER
      44. | 6.44 MALAYSIA MARKET ANALYSIS BY TYPE
      45. | 6.45 MALAYSIA MARKET ANALYSIS BY APPLICATION
      46. | 6.46 MALAYSIA MARKET ANALYSIS BY END USER
      47. | 6.47 THAILAND MARKET ANALYSIS BY TYPE
      48. | 6.48 THAILAND MARKET ANALYSIS BY APPLICATION
      49. | 6.49 THAILAND MARKET ANALYSIS BY END USER
      50. | 6.50 INDONESIA MARKET ANALYSIS BY TYPE
      51. | 6.51 INDONESIA MARKET ANALYSIS BY APPLICATION
      52. | 6.52 INDONESIA MARKET ANALYSIS BY END USER
      53. | 6.53 REST OF APAC MARKET ANALYSIS BY TYPE
      54. | 6.54 REST OF APAC MARKET ANALYSIS BY APPLICATION
      55. | 6.55 REST OF APAC MARKET ANALYSIS BY END USER
      56. | 6.56 SOUTH AMERICA MARKET ANALYSIS
      57. | 6.57 BRAZIL MARKET ANALYSIS BY TYPE
      58. | 6.58 BRAZIL MARKET ANALYSIS BY APPLICATION
      59. | 6.59 BRAZIL MARKET ANALYSIS BY END USER
      60. | 6.60 MEXICO MARKET ANALYSIS BY TYPE
      61. | 6.61 MEXICO MARKET ANALYSIS BY APPLICATION
      62. | 6.62 MEXICO MARKET ANALYSIS BY END USER
      63. | 6.63 ARGENTINA MARKET ANALYSIS BY TYPE
      64. | 6.64 ARGENTINA MARKET ANALYSIS BY APPLICATION
      65. | 6.65 ARGENTINA MARKET ANALYSIS BY END USER
      66. | 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
      67. | 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
      68. | 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
      69. | 6.69 MEA MARKET ANALYSIS
      70. | 6.70 GCC COUNTRIES MARKET ANALYSIS BY TYPE
      71. | 6.71 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
      72. | 6.72 GCC COUNTRIES MARKET ANALYSIS BY END USER
      73. | 6.73 SOUTH AFRICA MARKET ANALYSIS BY TYPE
      74. | 6.74 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
      75. | 6.75 SOUTH AFRICA MARKET ANALYSIS BY END USER
      76. | 6.76 REST OF MEA MARKET ANALYSIS BY TYPE
      77. | 6.77 REST OF MEA MARKET ANALYSIS BY APPLICATION
      78. | 6.78 REST OF MEA MARKET ANALYSIS BY END USER
      79. | 6.79 KEY BUYING CRITERIA OF HEALTHCARE
      80. | 6.80 RESEARCH PROCESS OF MRFR
      81. | 6.81 DRO ANALYSIS OF HEALTHCARE
      82. | 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
      83. | 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
      84. | 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
      85. | 6.85 HEALTHCARE, BY TYPE, 2024 (% SHARE)
      86. | 6.86 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
      87. | 6.87 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
      88. | 6.88 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
      89. | 6.89 HEALTHCARE, BY END USER, 2024 (% SHARE)
      90. | 6.90 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
      91. | 6.91 BENCHMARKING OF MAJOR COMPETITORS
    7. LIST OF TABLES
      1. | 7.1 LIST OF ASSUMPTIONS
      2. | | 7.1.1
      3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      5. | | 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
      6. | | 7.2.3 BY END USER, 2025-2035 (USD Billion)
      7. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
      8. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
      9. | | 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
      10. | | 7.3.3 BY END USER, 2025-2035 (USD Billion)
      11. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      12. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
      13. | | 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
      14. | | 7.4.3 BY END USER, 2025-2035 (USD Billion)
      15. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      16. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
      17. | | 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
      18. | | 7.5.3 BY END USER, 2025-2035 (USD Billion)
      19. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      20. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
      21. | | 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
      22. | | 7.6.3 BY END USER, 2025-2035 (USD Billion)
      23. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      24. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
      25. | | 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
      26. | | 7.7.3 BY END USER, 2025-2035 (USD Billion)
      27. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
      28. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
      29. | | 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
      30. | | 7.8.3 BY END USER, 2025-2035 (USD Billion)
      31. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      32. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
      33. | | 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
      34. | | 7.9.3 BY END USER, 2025-2035 (USD Billion)
      35. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      36. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
      37. | | 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
      38. | | 7.10.3 BY END USER, 2025-2035 (USD Billion)
      39. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      40. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
      41. | | 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
      42. | | 7.11.3 BY END USER, 2025-2035 (USD Billion)
      43. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      44. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
      45. | | 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
      46. | | 7.12.3 BY END USER, 2025-2035 (USD Billion)
      47. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      48. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
      49. | | 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
      50. | | 7.13.3 BY END USER, 2025-2035 (USD Billion)
      51. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
      52. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
      53. | | 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
      54. | | 7.14.3 BY END USER, 2025-2035 (USD Billion)
      55. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
      56. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
      57. | | 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
      58. | | 7.15.3 BY END USER, 2025-2035 (USD Billion)
      59. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      60. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
      61. | | 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
      62. | | 7.16.3 BY END USER, 2025-2035 (USD Billion)
      63. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      64. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
      65. | | 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
      66. | | 7.17.3 BY END USER, 2025-2035 (USD Billion)
      67. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      68. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
      69. | | 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
      70. | | 7.18.3 BY END USER, 2025-2035 (USD Billion)
      71. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      72. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
      73. | | 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
      74. | | 7.19.3 BY END USER, 2025-2035 (USD Billion)
      75. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      76. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
      77. | | 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
      78. | | 7.20.3 BY END USER, 2025-2035 (USD Billion)
      79. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      80. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
      81. | | 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
      82. | | 7.21.3 BY END USER, 2025-2035 (USD Billion)
      83. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      84. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
      85. | | 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
      86. | | 7.22.3 BY END USER, 2025-2035 (USD Billion)
      87. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      88. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
      89. | | 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
      90. | | 7.23.3 BY END USER, 2025-2035 (USD Billion)
      91. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      92. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
      93. | | 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
      94. | | 7.24.3 BY END USER, 2025-2035 (USD Billion)
      95. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      96. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
      97. | | 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
      98. | | 7.25.3 BY END USER, 2025-2035 (USD Billion)
      99. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      100. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
      101. | | 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
      102. | | 7.26.3 BY END USER, 2025-2035 (USD Billion)
      103. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      104. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
      105. | | 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
      106. | | 7.27.3 BY END USER, 2025-2035 (USD Billion)
      107. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      108. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
      109. | | 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
      110. | | 7.28.3 BY END USER, 2025-2035 (USD Billion)
      111. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      112. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
      113. | | 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
      114. | | 7.29.3 BY END USER, 2025-2035 (USD Billion)
      115. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      116. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
      117. | | 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
      118. | | 7.30.3 BY END USER, 2025-2035 (USD Billion)
      119. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
      120. | | 7.31.1
      121. | 7.32 ACQUISITION/PARTNERSHIP
      122. | | 7.32.1

    Spinal Needles Market Segmentation

    Spinal Needles Models Type Outlook (USD Billion, 2018-2030)

    • Pencil-Point Needles
    • Directional Spinal Needles
    • Atraumatic Needles

    Spinal Needles Application Outlook (USD Billion, 2018-2030)

    • Therapeutic
    • Diagnostic

    Spinal Needles End User Outlook (USD Billion, 2018-2030)

    • Hospitals & Clinics
    • Diagnostic Centers
    • Research Laboratories
    • Speciality Centres

    Spinal Needles Regional Outlook (USD Billion, 2018-2030)

    • North America Outlook (USD Billion, 2018-2030)

      • North America Spinal Needles by Type
        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • North America Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • North America Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres

      • US Outlook (USD Billion, 2018-2030)

      • US Spinal Needles by Type
        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • US Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • US Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Canada Outlook (USD Billion, 2018-2030)

      • Canada Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Canada Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Canada Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
    • Europe Outlook (USD Billion, 2018-2030)

      • Europe Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Europe Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Europe Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Germany Outlook (USD Billion, 2018-2030)

      • Germany Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Germany Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Germany Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • France Outlook (USD Billion, 2018-2030)

      • France Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • France Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • France Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • UK Outlook (USD Billion, 2018-2030)

      • UK Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • UK Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • UK Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Italy Outlook (USD Billion, 2018-2030)

      • Italy Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Italy Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Italy Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Spain Outlook (USD Billion, 2018-2030)

      • Spain Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Spain Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Spain Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Rest of Europe Outlook (USD Billion, 2018-2030)

      • Rest of Europe Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Rest of Europe Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Rest of Europe Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
    • Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Asia-Pacific Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Asia-Pacific Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Asia-Pacific Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • China Outlook (USD Billion, 2018-2030)

      • China Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • China Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • China Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Japan Outlook (USD Billion, 2018-2030)

      • Japan Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Japan Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Japan Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • India Outlook (USD Billion, 2018-2030)

      • India Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • India Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • India Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Australia Outlook (USD Billion, 2018-2030)

      • Australia Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Australia Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Australia Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • South Korea Outlook (USD Billion, 2018-2030)

      • South Korea Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • South Korea Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • South Korea Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Rest of Asia-Pacific Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Rest of Asia-Pacific Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Rest of Asia-Pacific Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
    • Rest of the World Outlook (USD Billion, 2018-2030)

      • Rest of the World Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Rest of the World Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Rest of the World Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Middle East Outlook (USD Billion, 2018-2030)

      • Middle East Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Middle East Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Middle East Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Africa Outlook (USD Billion, 2018-2030)

      • Africa Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Africa Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Africa Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
        • Speciality Centres
      • Latin America Outlook (USD Billion, 2018-2030)

      • Latin America Spinal Needles by Type

        • Pencil-Point Needles
        • Directional Spinal Needles
        • Atraumatic Needles
      • Latin America Spinal Needles by Application

        • Therapeutic
        • Diagnostic
      • Latin America Spinal Needles by End User

        • Hospitals & Clinics
        • Diagnostic Centers
        • Research Laboratories
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions